Evidence map›Paper›PMID 42327799›Full record

ArticleFrontiers in neurology

Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a

Christian Lampl, Richard B Lipton, Sarah Lipsius, Janet H Ford, Grazia Dell'Agnello, Lars Viktrup, Dawn C Buse

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03559257 (A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03559257 phase3completednot on this map

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults With Treatment-Resistant Migraine - the CONQUER Study

TypeinterventionalSponsorEli Lilly and CompanyRan2018 to 2019Enrolled463ConditionsMigraineArmsGalcanezumab, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christian LamplHospital Barmherzige Brüder Linz, Linz, Austria.
Richard B LiptonAlbert Einstein College of Medicine, Bronx, NY, United States.
Sarah LipsiusSyneos Health, Morrisville, NC, United States.
Janet H FordEli Lilly and Company, Indianapolis, IN, United States.
Grazia Dell'AgnelloEli Lilly and Company, Indianapolis, IN, United States.
Lars ViktrupEli Lilly and Company, Indianapolis, IN, United States.
Dawn C BuseAlbert Einstein College of Medicine, Bronx, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People with migraine report reduced health-related quality of life during ictal and interictal phases. However, most patient-reported outcome measures (PROMs) focus on impact during migraine episodes (ictal) or globally (both ictal and interictal), potentially neglecting interictal burden. This exploratory analysis evaluated correlations between the 4-item Migraine Interictal Burden Scale (MIBS-4) total score and other PROMs in people with migraine. Methods: A Results: A total of 462 participants were included (mean age: 45.8 years); 85.9% were female, 58.2% had episodic migraine and 41.8% had chronic migraine. At baseline, highest correlations with MIBS-4 were observed for Migraine Specific Quality of Life Questionnaire (MSQ)-total score, MSQ-Emotional Function (MSQ-EF), and the Patient Health Questionnaire (PHQ-9) score, which measures depressive symptoms (all Conclusion: Interictal burden, as assessed by MIBS-4, was moderately correlated with PROMs like MSQ, PHQ-9, and MIDAS, but moderate-negligible to low correlation was observed with monthly migraine headache days. These results indicate that interictal burden is a unique construct that is correlated with, but not fully captured by, other measures and should be considered when managing people with migraine. Clinical trial registration: ClinicalTrials.gov identifier NCT03559257.

Indexed as

correlationdisabilityinterictal burdenmigrainepatient-reported outcomesquality-of-life

Identifiers

PMID42327799
PMCPMC13281396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.